{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:53:21Z","timestamp":1774356801688,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Opioid use is increasingly prevalent amongst patients with inflammatory bowel disease (IBD), but whether opioids have deleterious effects, or their use is merely linked with more severe disease, is unclear. We conducted a longitudinal follow-up study examining this issue.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data on demographics, gastrointestinal and psychological symptoms, quality of life, and opioid use were recorded at baseline. Data on healthcare use and adverse disease outcomes were obtained from a review of electronic medical records at 12 months. Characteristics at baseline of those using opioids and those who were not were compared, in addition to occurrence of flare, prescription of glucocorticosteroids, treatment escalation, hospitalization, or intestinal resection during the 12 months of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 1029 eligible participants, 116 (11.3%) were taking opioids at baseline. Medium (odds ratio [OR],\u20054.67; 95% confidence interval [CI], 1.61-13.6) or high (OR, 8.03; 95% CI, 2.21-29.2) levels of somatoform symptom-reporting and use of antidepressants (OR, 2.54; 95% CI, 1.34-4.84) or glucocorticosteroids (OR, 6.63; 95% CI, 2.26-19.5; P\u2005&amp;lt;\u2005.01 for all analyses) were independently associated with opioid use. Following multivariate analysis, opioid users were significantly more likely to undergo intestinal resection (hazard ratio, \u20057.09; 95% CI, 1.63 to 30.9; P\u2005=\u2005.009), particularly when codeine or dihydrocodeine were excluded (hazard ratio,\u200542.9; 95% CI, 3.36 to 548; P\u2005=\u2005.004).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Opioid use in IBD is associated with psychological comorbidity and increased risk of intestinal resection, particularly in stronger formulations. Future studies should stratify the risk of individual opioids, so that robust prescribing algorithms can be developed and assess whether addressing psychological factors in routine IBD care could be an effective opioid avoidance strategy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izad256","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T12:55:51Z","timestamp":1699275351000},"page":"1724-1731","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study"],"prefix":"10.1093","volume":"30","author":[{"given":"Christy","family":"Riggott","sequence":"first","affiliation":[{"name":"Leeds Gastroenterology Institute, St. James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Medical Research at St. James\u2019s, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keeley M","family":"Fairbrass","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, St. James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Medical Research at St. James\u2019s, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P","family":"Selinger","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, St. James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Medical Research at St. James\u2019s, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Gracie","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, St. James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Medical Research at St. James\u2019s, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-4359","authenticated-orcid":false,"given":"Alexander C","family":"Ford","sequence":"additional","affiliation":[{"name":"Leeds Gastroenterology Institute, St. James\u2019s University Hospital , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Medical Research at St. James\u2019s, University of Leeds , Leeds ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"issue":"6","key":"2024100305542884000_CIT0001","doi-asserted-by":"crossref","first-page":"e0156666","DOI":"10.1371\/journal.pone.0156666","article-title":"Pain in IBD patients: very frequent and frequently insufficiently taken into account","volume":"11","author":"Zeitz","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"2024100305542884000_CIT0002","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00384-020-03727-3","article-title":"Abdominal pain in quiescent inflammatory bowel disease","volume":"36","author":"Coates","year":"2021","journal-title":"Int J Colorectal Dis."},{"issue":"6","key":"2024100305542884000_CIT0003","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1053\/j.gastro.2018.01.027","article-title":"Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease","volume":"154","author":"Gracie","year":"2018","journal-title":"Gastroenterology."},{"issue":"8","key":"2024100305542884000_CIT0004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S2468-1253(19)30089-5","article-title":"The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment","volume":"4","author":"Gracie","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"2024100305542884000_CIT0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/ajg.2016.59","article-title":"Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease","volume":"111","author":"Gracie","year":"2016","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2024100305542884000_CIT0006","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/apt.14493","article-title":"Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease","volume":"47","author":"Sweeney","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2024100305542884000_CIT0007","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ajg.2012.260","article-title":"Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis","volume":"107","author":"Halpin","year":"2012","journal-title":"Am J Gastroenterol."},{"issue":"12","key":"2024100305542884000_CIT0008","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"2024100305542884000_CIT0009","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/apt.14606","article-title":"Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn\u2019s disease and ulcerative colitis exacerbation","volume":"47","author":"Moninuola","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2024100305542884000_CIT0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11894-014-0410-4","article-title":"Narcotic bowel syndrome and opioid-induced constipation","volume":"16","author":"Szigethy","year":"2014","journal-title":"Curr Gastroenterol Rep."},{"issue":"5","key":"2024100305542884000_CIT0011","first-page":"357","article-title":"Toxic megacolon in ulcerative coltiis","volume":"90","author":"Silverberg","year":"1964","journal-title":"Can Med Assoc J."},{"issue":"5","key":"2024100305542884000_CIT0012","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ibd.21806","article-title":"Narcotic use for inflammatory bowel disease and risk factors during hospitalization","volume":"18","author":"Long","year":"2012","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2024100305542884000_CIT0013","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10620-019-05906-x","article-title":"Pain in inflammatory bowel disease is not improved during hospitalization: The impact of opioids on pain and healthcare utilization","volume":"65","author":"Berry","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"10","key":"2024100305542884000_CIT0014","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/ibd\/izy222","article-title":"Starting young: trends in opioid therapy among US adolescents and young adults with inflammatory bowel disease in the Truven MarketScan Database between 2007 and 2015","volume":"24","author":"Wren","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2024100305542884000_CIT0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"2024100305542884000_CIT0016","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ibd.20847","article-title":"Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study","volume":"15","author":"Hanson","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2024100305542884000_CIT0017","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Niccum","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"13","key":"2024100305542884000_CIT0018","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1097\/01.MIB.0000435442.07237.a4","article-title":"The burden of comedication among patients with inflammatory bowel disease","volume":"19","author":"Buckley","year":"2013","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2024100305542884000_CIT0019","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/dar.12089","article-title":"Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011","volume":"33","author":"Fischer","year":"2014","journal-title":"Drug Alcohol Rev."},{"issue":"12","key":"2024100305542884000_CIT0020","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/ibd\/izz100","article-title":"Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease","volume":"25","author":"Alley","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"8","key":"2024100305542884000_CIT0021","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamasurg.2015.5558","article-title":"Association of preoperative narcotic use with postoperative complications and prolonged length of hospital stay in patients With Crohn disease","volume":"151","author":"Li","year":"2016","journal-title":"JAMA Surg"},{"issue":"10","key":"2024100305542884000_CIT0022","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2024100305542884000_CIT0023","doi-asserted-by":"crossref","first-page":"304","DOI":"10.14309\/ajg.0000000000002063","article-title":"Characteristics and effect of anxiety and depression trajectories in inflammatory bowel disease","volume":"118","author":"Fairbrass","year":"2022","journal-title":"Am J Gastroenterol."},{"issue":"8167","key":"2024100305542884000_CIT0024","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet."},{"issue":"1","key":"2024100305542884000_CIT0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/tmj.2018.0264","article-title":"The Harvey-Bradshaw Index adapted to a mobile application compared with in-clinic assessment: the MediCrohn Study","volume":"26","author":"Echarri","year":"2020","journal-title":"Telemed J E Health."},{"issue":"1","key":"2024100305542884000_CIT0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut."},{"issue":"4","key":"2024100305542884000_CIT0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cgh.2010.01.001","article-title":"Correlation between the Crohn\u2019s disease activity and Harvey-Bradshaw indices in assessing Crohn\u2019s disease severity","volume":"8","author":"Vermeire","year":"2010","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"2024100305542884000_CIT0028","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/00365520310000654","article-title":"Defining relapse of ulcerative colitis using a symptom-based activity index","volume":"38","author":"Jowett","year":"2003","journal-title":"Scand J Gastroenterol."},{"issue":"6","key":"2024100305542884000_CIT0029","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"issue":"6","key":"2024100305542884000_CIT0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2036.2010.04402.x","article-title":"The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease","volume":"32","author":"Spiller","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2024100305542884000_CIT0031","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med."},{"issue":"8","key":"2024100305542884000_CIT0032","first-page":"1571","article-title":"The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease CCRPT Investigators Canadian Crohn\u2019s Relapse Prevention Trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2024100305542884000_CIT0033","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2016.02.014","article-title":"Rome IV diagnostic questionnaires and tables for investigators and clinicians","volume":"150","author":"Palsson","year":"2016","journal-title":"Gastroenterology."},{"issue":"Suppl 1","key":"2024100305542884000_CIT0034","first-page":"A137","article-title":"Opioid exposure in IBD and associated factors: A UK prospective multicentre audit of 1209 patients","volume":"71","author":"Bailie","year":"2022","journal-title":"Gut."},{"key":"2024100305542884000_CIT0035","year":"2022"},{"issue":"5","key":"2024100305542884000_CIT0036","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2024100305542884000_CIT0037","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ait.2020.94756","article-title":"The opioid crisis in North America: facts and future lessons for Europe","volume":"52","author":"Ayoo","year":"2020","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"2","key":"2024100305542884000_CIT0038","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00384-021-04076-5","article-title":"Post-operative morbidity in Crohn\u2019s disease: what is the impact of patient-, disease- and surgery-related factors","volume":"37","author":"Luglio","year":"2022","journal-title":"Int J Colorectal Dis."},{"issue":"8","key":"2024100305542884000_CIT0039","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-018-0660-4","article-title":"Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics","volume":"41","author":"Murphy","year":"2018","journal-title":"Drug Saf."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izad256\/52713836\/izad256.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/10\/1724\/59547834\/izad256.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/10\/1724\/59547834\/izad256.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T05:54:39Z","timestamp":1727934879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/10\/1724\/7334493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,31]]},"published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izad256","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2023,10,31]]}}}